Article
Role of Next-Generation Sequencing as a Diagnostic Tool for the Evaluation of Bone and Soft-Tissue Tumors.
Pathobiology : journal of immunopathology, molecular and cellular biology - 1 Jan 2017
Szurian Kinga, Kashofer Karl, Liegl-Atzwanger Bernadette
Abstract excerpt
Bone and soft-tissue tumors are in general rare. Diagnosing these tumors is challenging based on the significant number of different tumor entities, the rareness of these tumors, and the considerable morphological heterogeneity which can be found within a single tumor entity. Considering that more than half of the described soft-tissue tumors and approximately 25% of the bone tumors harbor recurrent genetic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
